[Melatoninergic antidepressant valdoxan]

Abstract

Data on the pharmacological properties, mechanism of action, and clinical advantages of the new antidepressant drug valdoxan capable of selectively stimulating melatonin receptors are presented. The drug effect is compared to the action of epiphyseal hormone melatonin and traditional antidepressants.